WallStreetZenWallStreetZen

NASDAQ: GYRE
Gyre Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Gyre Therapeutics earnings were $7.3M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest GYRE earnings report on Mar 31, 2025 announced Q1 2025 earnings of $2.7M, down 2,825.3% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, GYRE reported annual earnings of $12.1M, with -113% growth.

GYRE past earnings growth

How has GYRE's earnings growth performed historically?

Company
N/A
Industry
11.53%
Market
34%
GYRE's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
GYRE's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance

GYRE earnings history

Current Revenue
$100.6M
Current Earnings
$7.3M
Current Profit Margin
7.2%

GYRE Return on Equity

Current Company
11.4%
Current Industry
-60.2%
Current Market
31.5%
GYRE's Return on Equity (11.4%)... subscribe to Premium to read more.
High Return on Equity Performance

GYRE undefined

Current Company
5.8%
Current Industry
-2.5%
GYRE is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when GYRE announces earnings.

GYRE undefined

Current Company
9.86%
Current Industry
5.8%
GYRE has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

GYRE vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
GYRE$13.36M$7.25M-89.29%$0.08
IOVA-$333.86M-$375.36MN/A-$1.23
REPL-$235.43M-$247.30MN/A-$3.07
IMTX-$6.10M-$24.25MN/A-$0.17
PHAT-$272.12M-$345.79MN/A-$5.19
View Top Biotech Stocks

Gyre Therapeutics Earnings Reports & History FAQ

What were Gyre Therapeutics's earnings last quarter?

On GYRE's earnings call on Invalid Date, Gyre Therapeutics (NASDAQ: GYRE) reported Q1 2025 earnings per share (EPS) of $0.03, up 66.67% year over year. Total GYRE earnings for the quarter were $2.70 million. In the same quarter last year, Gyre Therapeutics's earnings per share (EPS) was $0.09.

If you're new to stock investing, here's how to buy Gyre Therapeutics stock.

Is Gyre Therapeutics profitable or losing money?

As of the last Gyre Therapeutics earnings report, Gyre Therapeutics is currently profitable. Gyre Therapeutics's net profit (also called net income) for the twelve months ending Mar 31, 2025 was $7.25 million, a 108.27% decrease year over year.

What was GYRE's earnings growth in the past year?

As of Gyre Therapeutics's earnings date in Invalid Date, Gyre Therapeutics's earnings has grown year over year. GYRE earnings in the past year totalled $7.25 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.